DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Souers AJ, Leverson JD, Boghaert ER. , et al.
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.
Nat Med 2013;
19 (02) 202-208
We do not assume any responsibility for the contents of the web pages of other providers.